[HER-ErbB family of receptors and their ligands: mechanisms of activation, signals and deregulation in cancer].
The topic of this review is first to analyze in normal conditions the signal transduction pathways induced by members of the HER-ErbB receptor family and their ligands, and second, to decipher some deregulations occurring in various cancer types. As a result, new therapeutic opportunities will be mentioned.